Bevacizumab Hypertension Risk Score

Assess and grade bevacizumab-induced hypertension (class effect of VEGF inhibitors) using baseline BP, risk factors, and CTCAE grading to guide antihypertensive prophylaxis and dose modification.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assess and grade bevacizumab-induced hypertension (class effect of VEGF inhibitors) using baseline BP, risk factors, and CTCAE grading to guide antihypertensive prophylaxis and dose modification

Each component has a specific meaning:

  • Baseline BP — The baseline bp recorded for the scenario being assessed.
  • Risk factors — The risk factors recorded for the scenario being assessed.
  • CTCAE grading — The ctcae grading recorded for the scenario being assessed.

Note: Interpret the bevacizumab htn risk result against the thresholds and context described above.

How to Use

Enter the baseline BP, risk factors, CTCAE grading for the scenario you are assessing. Assess and grade bevacizumab-induced hypertension (class effect of VEGF inhibitors) using baseline BP, risk factors, and CTCAE grading to guide antihypertensive prophylaxis and dose modification. Use the bevacizumab htn risk result to inform your calculation.

Frequently Asked Questions